Suppr超能文献

糖尿病并发症。患病率、检测、当前治疗及预后。

Complications of diabetes. Prevalence, detection, current treatment, and prognosis.

作者信息

Clements R S, Bell D S

出版信息

Am J Med. 1985 Nov 15;79(5A):2-7. doi: 10.1016/0002-9343(85)90503-0.

Abstract

The late complications associated with diabetes mellitus affect the eye (retinopathy and cataract), the kidney (diabetic glomerulosclerosis), the nerves (mononeuropathies, distal symmetric polyneuropathy, and autonomic neuropathy), and the large blood vessels (coronary artery, cerebrovascular, and peripheral vascular disease). With the exception of large blood vessel disease, evidence in animals and humans has suggested that the development of diabetes-associated complications is related to metabolic abnormalities associated with hyperglycemia. Although the exact mechanism by which hyperglycemia causes damage in individual tissues is unknown, a number of potentially pathogenic mechanisms have been proposed. These include increased activity of the polyol pathway, disturbance in the metabolism of myo-inositol and its phospholipid derivatives, abnormal permeability of the small blood vessels, and excessive glycosylation of various proteins. With the introduction of potent aldose reductase inhibitors, the role of increased activity of the polyol pathway (and related abnormalities in myo-inositol metabolism) in the pathogenesis of diabetes-associated complications can be clarified.

摘要

糖尿病相关的晚期并发症会影响眼睛(视网膜病变和白内障)、肾脏(糖尿病肾小球硬化症)、神经(单神经病、远端对称性多发性神经病和自主神经病变)以及大血管(冠状动脉、脑血管和外周血管疾病)。除大血管疾病外,动物和人类的证据均表明,糖尿病相关并发症的发生与高血糖相关的代谢异常有关。尽管高血糖导致个体组织损伤的确切机制尚不清楚,但已提出了一些潜在的致病机制。这些机制包括多元醇途径活性增加、肌醇及其磷脂衍生物代谢紊乱、小血管通透性异常以及各种蛋白质过度糖基化。随着强效醛糖还原酶抑制剂的引入,多元醇途径活性增加(以及肌醇代谢的相关异常)在糖尿病相关并发症发病机制中的作用得以阐明。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验